Link Pharma Chem Ltd
- Market cap
- ₹ 11 Cr.
- P/E
- 76.1x
- P/B
- 0.89x
- 52-week range
- 21 – 36.5
- ROE
- 1%
- ROCE
- 3.5%
- Dividend yield
- 0%
- Debt / equity
- 0.57
- Sector
- Chemicals & Petrochemicals
- Industry
- Commodity Chemicals
- Listed on
- BSE
About
Link Pharma Chem Limited is a chemical manufacturing company. The Company is engaged in manufacturing and exporting multi range intermediates for pharmaceutical, agro-industries and specialty chemicals. It has its manufacturing location at Nandesari in Gujarat. It has one production unit engaged in the manufacturing and job work of organic intermediates. It is also involved in custom synthesis / contract manufacturing for multistage synthesis for small, medium, and large companies. It offers services, such as contract manufacturing facilities, development of multistep pathways for organic synthesis, and refinement and optimization of existing synthetic methods. The Company's in-house testing laboratory has various facilities, such as high-performance liquid chromatography (HPLC) testing facilities, gas liquid chromatography (GLC) testing facilities, ultraviolet spectrophotometer testing facilities, Karl-Fisher instruments for moisture/water content measurement, and others.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Commodity Chemicals: 75 companies →Link Pharma Chem Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)76.1 against a typical 22.3: pricier than most peers (1st = cheapest).60th of 72
- Sales growth+12.3% against a typical +12.7% from a year earlier.34th of 65
- Profit growth−20% against a typical +13.6% from a year earlier.32nd of 49
- Share price, 3 months+4.6% against a typical −2.2%.19th of 65
- Size₹ 11.1 Cr. market value against a typical ₹ 131.2 Cr. (1st = largest).61st of 69
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6 | 8 | 8 | 9 | 5 | 5 | 6 | 8 | 6 | 7 | 7 | 9 |
| Expenses | 7 | 8 | 7 | 8 | 5 | 5 | 7 | 7 | 6 | 6 | 7 | 8 |
| Operating Profit | −1 | 0 | 1 | 1 | −0 | 0 | −0 | 1 | 0 | 1 | −0 | 0 |
| OPM % | −14.6% | 3.5% | 11.3% | 6.2% | −6.3% | 2.1% | −3.6% | 8.2% | 5.4% | 10.3% | −3.6% | 5.1% |
| Other Income | −0 | 0 | −0 | 0 | 0 | −1 | 0 | 0 | 0 | −0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −1 | 0 | 0 | 0 | −0 | −1 | −0 | 1 | 0 | 0 | −0 | 0 |
| Tax % | −26.6% | −46.7% | 45.7% | 16.7% | −20.5% | −24.4% | −26.5% | 21.6% | 0% | 40% | −16.3% | 18% |
| Net Profit | −1 | 0 | 0 | 0 | −0 | −1 | −0 | 0 | 0 | 0 | −0 | 0 |
| EPS in Rs | −2.3 | 0.5 | 0.59 | 0.68 | −0.7 | −1.51 | −0.79 | 0.9 | 0.05 | 0.16 | −0.92 | 0.72 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 8%
- 5 Years
- −5%
- 3 Years
- −11%
- TTM
- 16%
- 10 Years
- 7%
- 5 Years
- −42%
- 3 Years
- −48%
- TTM
- 100%
- 10 Years
- 10%
- 5 Years
- −4%
- 3 Years
- −19%
- TTM
- —
- 10 Years
- 4%
- 5 Years
- −1%
- 3 Years
- −6%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Link Pharma Chem Ltd | ₹ 25.60 | ₹ 11 Cr. | 76.1x | 0.9x | 1% | — |
| Sun Pharmaceutical Industries | ₹ 1,743.00 | ₹ 4,18,194 Cr. | 37.1x | 5.4x | — | 19.8% |
| Divi's Laboratories | ₹ 8,984.00 | ₹ 2,38,497 Cr. | 96x | 15x | — | 26.1% |
| Torrent Pharmaceuticals | ₹ 4,482.00 | ₹ 1,70,475 Cr. | 75.3x | 19.9x | — | 13.7% |
| Zydus Lifesciences | ₹ 1,127.85 | ₹ 1,12,503 Cr. | 20.9x | 4.2x | — | 15.7% |
| Cipla | ₹ 1,337.00 | ₹ 1,08,011 Cr. | 26.5x | 3.2x | — | 11.9% |
Management
- Sathish G. Thakur
- Chairman of the Board, Whole-time Director
- Sanjib Dutta
- Chief Financial Officer
- Komal Bhojwani
- Compliance Officer, Company Secretary
- Rishikesh Thakur
- Managing Director, Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.